Asset Allocation

As of December 31, 2024.
Type % Net
Cash 4.93%
Stock 47.31%
Bond 41.59%
Convertible 0.00%
Preferred 4.72%
Other 1.45%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2024
Large 96.31%
Mid 3.19%
Small 0.50%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 94.91%    % Emerging Markets: 3.97%    % Unidentified Markets: 1.11%

Americas 71.39%
71.39%
Canada 2.02%
United States 69.37%
0.00%
As of December 31, 2024. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 10.17%
United Kingdom 2.26%
7.90%
France 1.81%
Germany 1.81%
Italy 1.01%
Netherlands 1.69%
Switzerland 1.58%
0.00%
0.00%
Greater Asia 17.33%
Japan 2.19%
2.90%
Australia 1.22%
8.26%
Hong Kong 2.59%
Singapore 2.07%
Taiwan 3.60%
3.97%
China 1.75%
India 2.23%
Unidentified Region 1.11%

Bond Credit Quality Exposure

AAA 0.00%
AA 6.59%
A 9.32%
BBB 13.76%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 70.33%
Short Term 0.00%
As of December 31, 2024
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
15.72%
Materials
2.03%
Consumer Discretionary
4.54%
Financials
7.98%
Real Estate
1.17%
Sensitive
62.36%
Communication Services
7.70%
Energy
5.22%
Industrials
11.11%
Information Technology
38.33%
Defensive
17.82%
Consumer Staples
3.16%
Health Care
14.66%
Utilities
0.00%
Not Classified
4.10%
Non Classified Equity
4.10%
Not Classified - Non Equity
0.00%
As of May 31, 2024
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2024
Type % Net
Government 6.59%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 93.41%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.00%
Less than 1 Year
0.00%
Intermediate
100.0%
1 to 3 Years
41.20%
3 to 5 Years
42.39%
5 to 10 Years
16.41%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of December 31, 2024
View Bond Maturity Exposure
Start Trial